tirzepatide phase 3 mash Eli Lilly's Shows Promise in Treating Fatty Liver Disease Biomed Initiates Phase 3 Trials
Description
This trial design is bold enough to lead a new generation of CVOTs, but it introduces interpretive complexity
But waiting too long might slow improvement
Samantha M
